Companhia de Saneamento de Minas Gerais (CSMG3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jul, 2026Executive summary
Net revenue reached BRL 1.88 billion in 4Q25 (+6.9% YoY) and BRL 7.42 billion in 2025 (+5.6% YoY), driven by tariff adjustments, higher volumes, and operational efficiency.
EBITDA was BRL 731 million in 4Q25 (+14.1% YoY, 38.5% margin) and BRL 2.95 billion in 2025 (+5.7% YoY, 39.8% margin).
Net income rose to BRL 337 million in 4Q25 (+23.9% YoY) and BRL 1.42 billion in 2025 (+7.5% YoY), reflecting resilience and cost control.
Record CapEx of BRL 2.9 billion in 2025 (+32% YoY), focused on universalization, modernization, and efficiency, with a BRL 21 billion plan for 2026–2030.
Advanced ESG agenda, improved customer satisfaction (NPS 76.9%), and maintained low delinquency rates (2.91%).
Financial highlights
2025 net revenue: BRL 7.42 billion (+5.6% YoY); EBITDA: BRL 2.95 billion (+5.7% YoY, 39.8% margin); net income: BRL 1.42 billion (+7.5% YoY).
Operating cash generation for 2025 was BRL 2.3 billion, up nearly 13% YoY.
Dividends (regular and extraordinary) totaled BRL 853 million in 2025, with a 50% payout ratio.
Leverage at 2.3x Net Debt/EBITDA; net debt at BRL 6.9 billion as of year-end 2025.
Delinquency rate improved to 2.91%, a record low since 2020.
Outlook and guidance
CapEx guidance for 2026–2030 is BRL 21 billion, focused on universalization, water security, and loss reduction.
Tariff review effective January 2026, with a 6.56% average tariff increase and pre-tax WACC of 13.7%.
Board set a 50% payout policy for dividends in 2026, maintaining predictability.
Ongoing privatization process, with legal and governance structures in place for transition.
Latest events from Companhia de Saneamento de Minas Gerais
- Net income up 30.4% and EBITDA margin at 41.4%, with record investments and higher dividends.CSMG3
Q2 202416 Jul 2026 - Revenue up 6.8% to R$6.97B, EBITDA margin 39.7%, net income R$1.32B, record investments.CSMG3
Q4 202413 Jul 2026 - Net income fell 14.1% as investments and leverage rose, despite revenue growth and concession renewal.CSMG3
Q1 20269 Jul 2026 - Net revenue up 9.6%, adjusted net income up 9.3%, and EBITDA margin at 40.5%.CSMG3
Q3 20248 Jul 2026 - CapEx rose 26%, EBITDA margin held near 40%, and privatization and investments advanced.CSMG3
Q3 20256 Jul 2026 - Revenue up, profit down; investments and leverage rise amid regulatory changes.CSMG3
Q2 20256 Jul 2026 - Net income up 21.9% and investments up 45.9% year-over-year, with record-low delinquency.CSMG3
Q1 20256 Jul 2026